Abstract: The present invention provides compositions and methods for treating cancer or a metastasis thereof in a subject. In some embodiments, the methods involve administering a composition comprising therapeutically effective amount of at least one immune stimulator to the subject. In some embodiments, a combination of at least two immune stimulators is used for the treatment. In some embodiments, the combination includes an alpha thymosin peptide and an additional immune stimulator, and/or optionally one or more additional anti-cancer agents.
Type:
Grant
Filed:
October 21, 2015
Date of Patent:
August 8, 2017
Assignee:
SciClone Pharmaceuticals, Inc.
Inventors:
Robert S. King, Cynthia W. Tuthill, Friedhelm Blobel